Use of liposomal aminoglycoside formulation in the manufacture of a medicament for treating or ameliorating pulmonary infection

摘要

The present invention relates to formulations useful for the sustained release of antiinfectives. In particular, it relates to a liposomal anti-infective for use in treating or ameliorating a pulmonary infection in a patient, wherein the anti-infective is an aminoglycoside.